Dr. Hönle AG reported earnings results for the full year ended September 30, 2023. For the full year, the company reported sales was EUR 106.4 million compared to EUR 116.47 million a year ago. Net loss was EUR 11.01 million compared to EUR 13.36 million a year ago.

Basic loss per share from continuing operations was EUR 1.87 compared to basic earnings per share from continuing operations of EUR 0.44 a year ago. Diluted loss per share from continuing operations was EUR 1.87 compared to diluted earnings per share from continuing operations of EUR 0.44 a year ago. Basic loss per share was EUR 1.82 compared to EUR 2.2 a year ago.

Diluted loss per share was EUR 1.82 compared to EUR 2.2 a year ago.